Evaluation of Nitrobenzyl Derivatives of Camptothecin as Anti-Cancer Agents and Potential Hypoxia Targeting Prodrugs

about

Evaluation of Nitrobenzyl Derivatives of Camptothecin as Anti-Cancer Agents and Potential Hypoxia Targeting Prodrugs

Item

http://www.wikidata.org/entity/Q58692404

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 15 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Evaluation of Nitrobenzyl Deri ...... ial Hypoxia Targeting Prodrugs

@en

Evaluation of Nitrobenzyl Deri ...... ial Hypoxia Targeting Prodrugs

@nl

type

Item

label

Evaluation of Nitrobenzyl Deri ...... ial Hypoxia Targeting Prodrugs

@en

Evaluation of Nitrobenzyl Deri ...... ial Hypoxia Targeting Prodrugs

@nl

prefLabel

Evaluation of Nitrobenzyl Deri ...... ial Hypoxia Targeting Prodrugs

@en

Evaluation of Nitrobenzyl Deri ...... ial Hypoxia Targeting Prodrugs

@nl

P1476

Evaluation of Nitrobenzyl Deri ...... ial Hypoxia Targeting Prodrugs

@en

P2093

Brian B Hasinoff

http://www.w3.org/2001/XMLSchema#string

Dinghua Liang

http://www.w3.org/2001/XMLSchema#string

Xing Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and characterization of a novel human dual flavin reductase

Determination of the redox potentials and electron transfer properties of the FAD- and FMN-binding domains of the human oxidoreductase NR1

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

Chemical Redox Agents for Organometallic Chemistry

Targeting hypoxia in cancer therapy

Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia.

Determination of the redox properties of human NADPH-cytochrome P450 reductase.

Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment

Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302.

Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia.

P304

2041

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MOLECULES23082041

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David E Herbert

Geoffrey K. Tranmer

P577

2018-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30111719

http://www.w3.org/2001/XMLSchema#string

P921

hypoxia

P932

6222813

http://www.w3.org/2001/XMLSchema#string